Scientists have found success using the immune system's T-cells to target cancer cells. But, how exactly does T-cell cancer therapy work? This form of therapy is divided into two stages: In the first stage, a sample of the patient's T-cells (a type of white blood cell involved in fighting infections) is taken from their blood. These cells are then taken to the lab where they have genetically modified sensor cells, called antigen receptors, added to them. The second stage focuses on targeting cancer cells. Here, the modified cells are allowed to multiply. Then, these engineered T-cells are infused back into the patient where the new antigen receptors allow them to target and destroy the cancer. One of the researchers, Stanley Riddell, of the Fred Hutchinson Cancer Research Center in Washington state says that 'there are reasons to be optimistic, there are reasons to be pessimistic.' Studies have been conducted on 'patients that have failed everything. Most of the patients in our trial would be projected to have two to five months to live'. Researcher Chiara Bonini also showed enthusiasm, who said that she has not seen remission rates like those of recent trials in over 15 years, and has referred to this new treatment as a 'revolution'. The new treatment helps the patient's immune system better find and destroy cancer cells.

Scientists have found success using the immune system's T-cells to target cancer cells. But, how exactly does T-cell cancer therapy work? This form of therapy is divided into two stages:

In the first stage, a sample of the patient's T-cells (a type of white blood cell involved in fighting infections) is taken from their blood. These cells are then taken to the lab where they have genetically modified sensor cells, called antigen receptors, added to them.

The second stage focuses on targeting cancer cells. Here, the modified cells are allowed to multiply. Then, these engineered T-cells are infused back into the patient where the new antigen receptors allow them to target and destroy the cancer.

One of the researchers, Stanley Riddell, of the Fred Hutchinson Cancer Research Center in Washington state says that "there are reasons to be optimistic, there are reasons to be pessimistic." Studies have been conducted on "patients that have failed everything. Most of the patients in our trial would be projected to have two to five months to live". Researcher Chiara Bonini also showed enthusiasm, who said that she has not seen remission rates like those of recent trials in over 15 years, and has referred to this new treatment as a "revolution".
The new treatment helps the patient's immune system better find and destroy cancer cells. more

Helpful Fight Cancer Together Feb 18

Viewed by 395

View all 11 comments Below 11 comments

Brij Gupta

Mr Pratap, This is just a research information for prevention. To my knowledge, it is not yet available in India. more

Feb 19

Pratap Chandnani (Blood cancer awareness, stem cell transplants, lifestyle adoption. )

Mr Brij Gupta... where in India possible ? Any leads for this in US fora colleagues mother with Ovarian cancer tumor ? more

Feb 19

Ashok Dua

Does this line of treatment help in MS cases also? Is the treatment available in India as well? more

Feb 19

Jaysing Kurale

Thanks so much more

Feb 19

RAJU MESHRAM

My sincere Thanks for sharing information on T-Cell therapy, which helps in improving the immunity of patients and there by fight the cancer disease. more

Feb 19

View 11 more comment(s)